News 2024-04-19
Upcoming Porton Shows in Europe and the USA:Shaping Our Future Together
The Swiss Biotech Day, hosted by the Swiss Biotech Association, stands as one of Europe's leading biotechnology conferences. With a global reputation, last year's event drew over 1,800 participants from 44 countries. In 2024, the conference will once again serve as a hub for networking, insightful discussions, and the exploration of cutting-edge developments in R&D, manufacturing, data management, artificial intelligence, and innovative financing. Anticipated attendees include over 1,800 senior experts and 70 exhibitors, showcasing innovative biotech startups and medium-sized companies from the life sciences industry.
Do not miss this exceptional opportunity to engage in stimulating conversations, exchange valuable insights, and forge strategic partnerships that will shape the future of pharmaceutical development. For inquiries, please contact Dr. Angelo Manzo at angelo.manzo@portonpharma.com.
Porton Booth: # 310
Porton is a leading global CDMO service provider, offering a wide range of services to meet the needs of pharmaceutical professionals worldwide. We are committed to providing high-quality services that promote efficiency and innovation in the pharmaceutical industry.
CPHI NA is the premier pharmaceutical event in the Americas, providing a unique opportunity for attendees to connect with suppliers from across the industry and explore new business opportunities. Join us at Booth 310 to learn more about our cutting-edge technologies and how we can help you grow your business and expand your network in the pharma industry. Don't miss this chance to discover new opportunities for collaboration and growth. We look forward to seeing you at the heart of Pharma! For inquiries, please contact us at business@portonpharma.com.
We look forward to seeing you at the heart of Pharma @ Booth 310.
Porton Booth: # 24
Biotech Outsourcing Strategies Events which began in 2006 in Sheffield, UK, bring together stakeholders in R&D outsourcing to share experience, build existing outsourcing partnerships and forge new buyer/supplier business relationships. BOS is an event where business gets done and where you can be confident of high-quality interactions with potential business partners.
BOS Basel 2024's scope is primarily development stage CMC outsourcing for both Small Molecules and Biologics, as well as covering Novel Therapeutic Entities and will include a vibrant Exhibition showcasing expertise and capabilities from the CRO and CMO community.
As one of the participants of the upcoming BOS conference, Porton will have a booth to showcase our company's professional skills and capabilities. We sincerely invite industry professionals to visit our booth and discuss collaboration opportunities to promote the development of the R&D outsourcing industry, foster international cooperation, achieve innovative breakthroughs, and benefit global patients.
Look forward to exploring future collaboration opportunities with you. For inquiries, please contact us at business@portonpharma.com.
If you have any business needs, feel free to schedule a meeting in advance with our team of scientists and business professionals. Please contact us at business@portonpharma.com.
The 28th ACS Annual Green Chemistry & Engineering Conference
Date: June 2-5, 2024
Venue: Crowne Plaza Atlanta Perimeter at Ravinia, Atlanta, GA
BIO International
Date: June 3-6, 2024
Venue: San Diego Convention Center
13th Process Development for High Potent Drugs Summit-
Date: June 25-27
Venue: Delta Hotel Philadelphia Airport,500 Stevens Dr, Philadelphia, PA
Others
MoreNews 2024-10-31
Milestone | Comprehensive Enhancement of GMP Manufacturing Capacity and New Modality Service Capabilities at Porton Fengxian, Shanghai
Recently, Porton Pharma has achieved a significant capacity breakthrough at its GMP manufacturing facility in Fengxian, Shanghai, China, further enhancing its production capabilities and technological strength in new modality areas such as peptide and oligonucleotide drugs. This upgrade represents an important step in Porton's commitment to becoming a leading global CDMO company.
News 2024-10-24
Porton Pharma Solutions Signed Strategic Partnership with Shanghai InnoStar
On October 24, 2024, Porton Pharma SolutionsLtd. ("Porton") announced a strategic partnership with Shanghai InnoStar Bio-tech Co., Ltd. ("InnoStar") in Shanghai. The distinguished signing ceremony was attended by Mr. Ju Nianfeng, Chairman and CEO of Porton; Dr. Chang Yan, President of InnoStar; Ms. Pi Wei, Deputy General Manager of Porton; Ms. Fan Meng, Deputy General Manager of the Sales & Marketing Center, Dr. Fang Xin, Senior Director of Non-clinicalPharmacology BU at InnoStar, and Ms. Zhao Jie, Marketing Associate Director at InnoStar.